APA (7th ed.) Citation

A, M., MS, A., CE, T., SP, O., PL, S., C, Z., . . . JC, M. (2018). Targeting senescent cholangiocytes and activated fibroblasts with B-cell lymphoma-extra large inhibitors ameliorates fibrosis in multidrug resistance 2 gene knockout (Mdr2-/- ) mice. Hepatology (Baltimore, Md.), 67(1), 247. https://doi.org/10.1002/hep.29464

Chicago Style (17th ed.) Citation

A, Moncsek, et al. "Targeting Senescent Cholangiocytes and Activated Fibroblasts with B-cell Lymphoma-extra Large Inhibitors Ameliorates Fibrosis in Multidrug Resistance 2 Gene Knockout (Mdr2-/- ) Mice." Hepatology (Baltimore, Md.) 67, no. 1 (2018): 247. https://doi.org/10.1002/hep.29464.

MLA (9th ed.) Citation

A, Moncsek, et al. "Targeting Senescent Cholangiocytes and Activated Fibroblasts with B-cell Lymphoma-extra Large Inhibitors Ameliorates Fibrosis in Multidrug Resistance 2 Gene Knockout (Mdr2-/- ) Mice." Hepatology (Baltimore, Md.), vol. 67, no. 1, 2018, p. 247, https://doi.org/10.1002/hep.29464.